SPDR S&P Telecom ETF News - XTL | Aktien Amerikanische Börse

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Holding(s) in Company

XTL Biopharmaceuticals Limited ("XTLbio") Notification Of Major Interests In Shares XTLbio received notification from Israel Healthcare Ventures...

Holding(s) in Company

RNS Number:6145N Shore Capital Group PLC 16 July 2003 For Immediate Release 16 July 2003 Disposal of Holding in XTL...

XTLBIO STRATEGY UPDATE

XTLBIO STRATEGY UPDATE Rehovot, Israel, 15 July 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced today that as part of its continuing review...

XTLbio BOARD TAKES ACTION FOLLOWING AGM

XTLbio BOARD TAKES ACTION FOLLOWING AGM Rehovot, Israel, 25 June 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced today actions following...

Director Shareholding

RNS Number:6447M XTL Biopharmaceuticals Limited 23 June 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS...

XTLbio AGM STATEMENT

XTLbio AGM STATEMENT Rehovot, Israel, 19 June 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced that at its Annual General Meeting (AGM) held...

XTLbio REPORTS ENCOURAGING PK RESULTS FOR HepeX(TM)-B

XTLbio REPORTS ENCOURAGING PK RESULTS FOR HepeX(tm)-B Drug candidate meets or beats HBIg antibody levels while delivering 1,000-fold less protein...

XTLbio ADVANCES NEW DRUG CANDIDATE TO TREAT CHRONIC HCV

XTLbio ADVANCES NEW DRUG CANDIDATE TO TREAT CHRONIC HCV Rehovot, Israel, 4 June 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced today...

Notice of AGM

RNS Number:4636L XTL Biopharmaceuticals Limited 22 May 2003 XTL BIOPHARMACEUTICALS LTD Notification of Annual General Meeting On...

CHIEF SCIENTIST GRANT TO XTLbio DEFERRED

CHIEF SCIENTIST GRANT TO XTLbio DEFERRED Rehovot, Israel, 21 May 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced today that it has received...

XTLbio RESCHEDULES AGM FOR JUNE 19th

XTLbio RESCHEDULES AGM FOR JUNE 19th External directors address shareholders Rehovot, Israel, 20 May 2003 - XTL Biopharmaceuticals Ltd. (XTLbio...

Holding(s) in Company

Letter to XTL Biopharmaceuticals Ltd, dated 15 May 2003 Re: Holding in XTL Biopharmaceuticals Ltd. "This letter serves to confirm that as at the...

XTLbio CANCELS JUNE 3rd AGM

XTLbio CANCELS JUNE 3rd AGM Rehovot, Israel, 15 May 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) announced today that following a request by...

Director Shareholding

SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1. Name of Company XTL Biopharmaceuticals Limited 2. Name of Director...

XTLbio UPDATE ON REQUEST FOR NEW RESOLUTIONS AT AGM

XTLbio UPDATE ON REQUEST FOR NEW RESOLUTIONS AT AGM Rehovot, Israel, 13 May 2003 - XTL Biopharmaceuticals Ltd. (XTLbio) reported today an update...

1
2
Weiter

Rendering Error

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

SPDR S&P Telecom ETF (XTL)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

XTL Nachrichten

Holding(s) in Company

Holding(s) in Company

XTLBIO STRATEGY UPDATE

XTLbio BOARD TAKES ACTION FOLLOWING AGM

Director Shareholding

XTLbio AGM STATEMENT

XTLbio REPORTS ENCOURAGING PK RESULTS FOR HepeX(TM)-B

XTLbio ADVANCES NEW DRUG CANDIDATE TO TREAT CHRONIC HCV

Notice of AGM

CHIEF SCIENTIST GRANT TO XTLbio DEFERRED

XTLbio RESCHEDULES AGM FOR JUNE 19th

Holding(s) in Company

XTLbio CANCELS JUNE 3rd AGM

Director Shareholding

XTLbio UPDATE ON REQUEST FOR NEW RESOLUTIONS AT AGM

XTL Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

SPDR S&P Telecom ETF (XTL) News

SPDR S&P Telecom ETF (XTL)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

XTL Nachrichten

Holding(s) in Company

Holding(s) in Company

XTLBIO STRATEGY UPDATE

XTLbio BOARD TAKES ACTION FOLLOWING AGM

Director Shareholding

XTLbio AGM STATEMENT

XTLbio REPORTS ENCOURAGING PK RESULTS FOR HepeX(TM)-B

XTLbio ADVANCES NEW DRUG CANDIDATE TO TREAT CHRONIC HCV

Notice of AGM

CHIEF SCIENTIST GRANT TO XTLbio DEFERRED

XTLbio RESCHEDULES AGM FOR JUNE 19th

Holding(s) in Company

XTLbio CANCELS JUNE 3rd AGM

Director Shareholding

XTLbio UPDATE ON REQUEST FOR NEW RESOLUTIONS AT AGM

XTL Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen